Last reviewed · How we verify
ropivacaine, ketorolac and epinephrine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
ropivacaine, ketorolac and epinephrine (ropivacaine, ketorolac and epinephrine) — Region Örebro County.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ropivacaine, ketorolac and epinephrine TARGET | ropivacaine, ketorolac and epinephrine | Region Örebro County | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ropivacaine, ketorolac and epinephrine CI watch — RSS
- ropivacaine, ketorolac and epinephrine CI watch — Atom
- ropivacaine, ketorolac and epinephrine CI watch — JSON
- ropivacaine, ketorolac and epinephrine alone — RSS
Cite this brief
Drug Landscape (2026). ropivacaine, ketorolac and epinephrine — Competitive Intelligence Brief. https://druglandscape.com/ci/ropivacaine-ketorolac-and-epinephrine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab